The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report

JAAD Case Rep. 2024 May 4:50:141-143. doi: 10.1016/j.jdcr.2024.04.034. eCollection 2024 Aug.

Authors

Deesha Desai^{1

2}, Ambika Nohria², Kristen Lo Sicco², Jerry Shapiro²

Affiliations

¹ University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
² The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.

No abstract available

Keywords: JAK inhibitor; frontal fibrosing alopecia; ruxolitinib.

Publication types

Case Reports